A

Achilles Therapeutics PLC
NASDAQ:ACHL

Watchlist Manager
Achilles Therapeutics PLC
NASDAQ:ACHL
Watchlist
Price: 1.48 USD 0.68% Market Closed
Market Cap: 60.8m USD

Wall Street
Price Targets

ACHL Price Targets Summary
Achilles Therapeutics PLC

There are no price targets for ACHL.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Achilles Therapeutics PLC Competitors:
Price Targets
ANAB
AnaptysBio Inc
16% Upside
PHM
Pharma Mar SA
30% Upside
6628
Transcenta Holding Limited
586% Upside
BIOCON
Biocon Ltd
12% Upside
IMTX
Immatics NV
85% Upside
LVTX
LAVA Therapeutics NV
20% Downside
RNA
Avidity Biosciences Inc
3% Upside
2162
KeyMed Biosciences Inc
56% Upside

Revenue
Forecast

Revenue Estimate
Achilles Therapeutics PLC

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Achilles Therapeutics PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Achilles Therapeutics PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ACHL's stock price target?
Not Available

ACHL doesn't have any price targets made by Wall Street professionals.

Back to Top